European central nervous system disorders specialist Neuraxpharm is continuing expansion in the therapeutic area after striking a deal to acquire the narcolepsy brands Provigil (modafinil) and Nuvigil (armodafinil) “in most markets outside of the US.”
Neuraxpharm Picks Up A Pair Of Narcolepsy Drugs As Deal Frenzy Continues Apace
Deal Includes Provigil And Nuvigil Brands In ‘Most’ Non-US Markets
Neuraxpharm’s business development team remains busy entering the new year, after signing yet another strategic deal – this time to grow the firm’s core presence in CNS disorder drugs.
